1
|
Yasin MS, Al Karmi J, Suleiman DO, Raja YM, Alshrouf MA, Abu Halaweh A, Hamdan M, Samarah O. Acetabular index as an indicator of Pavlik harness success in grade I developmental dysplasia of the hip: A retrospective study. J Child Orthop 2023; 17:598-606. [PMID: 38050594 PMCID: PMC10693839 DOI: 10.1177/18632521231199519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Accepted: 08/16/2023] [Indexed: 12/06/2023] Open
Abstract
Purpose Some articles have focused on the effectiveness of the Pavlik harness treatment for unstable and dislocated hips, yet data on monitoring its effectiveness with the acetabular index remains elusive. Therefore, this study aimed to assess Pavlik harness effectiveness in infants ≤6 months diagnosed with grade I developmental dysplasia of the hip using acetabular index improvement and identify the possible predictors of successful Pavlik harness treatment. Methods A retrospective review of infants with grade I acetabular dysplasia treated with a Pavlik harness and monitored with anteroposterior pelvis X-rays at presentation and follow-up. Successful treatment was defined as achieving an acetabular index <30°. Results A total of 231 infants with acetabular dysplasia were treated with a Pavlik harness. A successful outcome was achieved in 135 infants (58.4%). Younger age, lower initial acetabular index, and patients with unilateral developmental dysplasia of the hip were significant predictors of a successful outcome. An age of 4.5 months or older was found to be the threshold for an unsuccessful result following Pavlik harness treatment, with a sensitivity of 65.2% and specificity of 57.3%. An initial acetabular index of 35.5° was found to be the threshold for an unsuccessful result, with a sensitivity of 83.7% and specificity of 61.5%. Conclusion Pavlik Harness's success in correcting the acetabular index in acetabular dysplasia patients was related to unilateral cases, a younger age at presentation, and a lower initial acetabular index. The thresholds for unsuccessful treatment were an age of 4.5 months or greater and an acetabular index of 35.5° or higher.
Collapse
Affiliation(s)
- Mohamad Samih Yasin
- Department of Special Surgery, Division of Orthopaedics, School of Medicine, The University of Jordan, Amman, Jordan
| | - Joud Al Karmi
- Faculty of Medicine, The University of Jordan, Amman, Jordan
| | | | | | - Mohammad A Alshrouf
- Medical Internship, Jordan University Hospital, The University of Jordan, Amman, Jordan
| | - Ahmad Abu Halaweh
- Department of Special Surgery, Division of Orthopaedics, School of Medicine, The University of Jordan, Amman, Jordan
| | - Mohammad Hamdan
- Department of Special Surgery, Division of Orthopaedics, School of Medicine, The University of Jordan, Amman, Jordan
| | - Omar Samarah
- Department of Special Surgery, Division of Orthopaedics, School of Medicine, The University of Jordan, Amman, Jordan
| |
Collapse
|
2
|
Håberg Ø, Bremnes T, Foss OA, Angenete O, Lian ØB, Holen KJ. Children treated for developmental dysplasia of the hip at birth and with normal acetabular index at 1 year: How many had residual dysplasia at 5 years? J Child Orthop 2022; 16:183-190. [PMID: 35800653 PMCID: PMC9254022 DOI: 10.1177/18632521221106376] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Accepted: 03/28/2022] [Indexed: 02/03/2023] Open
Abstract
PURPOSE The purpose of the study was to assess the effect of further follow-up for children treated for developmental dysplasia of the hip, with normal clinical and radiological findings at 1-year time point. The effect was quantified by the number of hips with a pathologic deterioration up to 5 years. METHODS Among 47,289 children born in Sør-Trøndelag county in Norway between 2003 and 2015, 265 children had developmental dysplasia of the hip. Of these, 164 children (239 hips) treated for developmental dysplasia of the hip with normal clinical findings and normal acetabular index at the 1-year time point were included in the study. The number of hips with pathologic acetabular index at the 5-year time point were reported. The diagnostic uncertainty related to radiological measurements was quantified together with the effect of introducing a second radiographic measurement, the center edge angle. RESULTS A total of 239 treated hips were normal at the 1-year time point. At 5-year time point, 10 (4.2%) hips had a pathologic acetabular index measurement and none classified to have developmental dysplasia of the hip caused by measurement inaccuracy. Eight (3.3%) hips had pathologic center edge angle measurement. Four hips had both pathologic acetabular index and center edge angle measurements, with three later treated with surgery. The intra- and interobserver repeatability coefficients were within 3.1°-6.6°. CONCLUSION The repeatability coefficient of the acetabular index measurements was high and no hips could be classified to have developmental dysplasia of the hip at the 5-year time point when taking this repeatability into account. Hips classified as pathologic combining acetabular index and center edge angle measurements were likely to be treated with surgery for residual dysplasia. We recommend further follow-up for these children. LEVEL OF EVIDENCE level II.
Collapse
Affiliation(s)
- Øyvind Håberg
- Department of Orthopedic Surgery,
Kristiansund Hospital, Kristiansund, Norway,Institute of Neuromedicine and Movement
Science, Faculty of Medicine and Health Services, NTNU, Trondheim, Norway,Øyvind Håberg, Department of Orthopedic
Surgery, Kristiansund Hospital, Herman Døhlens vei 1, N-6508 Kristiansund,
Norway.
| | - Thomas Bremnes
- Department of Radiology and Nuclear
Medicine, St. Olav’s Hospital, Trondheim University Hospital, Trondheim,
Norway
| | - Olav A Foss
- Institute of Neuromedicine and Movement
Science, Faculty of Medicine and Health Services, NTNU, Trondheim, Norway,Department of Orthopedic Surgery,
Trondheim University Hospital, Trondheim, Norway
| | - Oskar Angenete
- Department of Radiology and Nuclear
Medicine, St. Olav’s Hospital, Trondheim University Hospital, Trondheim,
Norway,Institute of Circulation and Medical
Imaging, Faculty of Medicine and Health Services, NTNU, Trondheim, Norway
| | - Øystein B Lian
- Department of Orthopedic Surgery,
Kristiansund Hospital, Kristiansund, Norway,Institute of Neuromedicine and Movement
Science, Faculty of Medicine and Health Services, NTNU, Trondheim, Norway
| | - Ketil J Holen
- Institute of Neuromedicine and Movement
Science, Faculty of Medicine and Health Services, NTNU, Trondheim, Norway,Department of Orthopedic Surgery,
Trondheim University Hospital, Trondheim, Norway
| |
Collapse
|